Loading...
XSHG600518
Market cap4.55bUSD
Dec 26, Last price  
2.40CNY
1D
0.00%
1Q
26.98%
Jan 2017
-86.55%
Name

Kangmei Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XSHG:600518 chart
P/E
323.73
P/S
6.81
EPS
0.01
Div Yield, %
0.00%
Shrs. gr., 5y
-3.80%
Rev. gr., 5y
-22.17%
Revenues
4.87b
+16.60%
553,110,449584,613,750825,606,6161,294,056,7331,727,164,1512,377,160,9013,308,801,6406,080,507,22511,165,154,81813,358,728,51715,949,188,76918,066,827,95221,642,324,07017,578,618,64017,065,079,13911,445,545,8105,412,007,9614,152,521,0994,180,150,3294,874,016,143
Net income
103m
71,210,12572,646,31399,889,496146,109,126294,575,387501,508,534715,522,7121,005,031,0181,441,191,4881,879,816,9942,285,879,1212,756,734,5983,340,403,6404,100,926,148374,492,320007,917,900,6230102,521,231
CFO
-318m
78,522,066133,131,86368,318,922162,553,1073,015,266119,466,024669,185,655574,964,0931,008,350,2051,674,010,6281,132,203,880508,863,2251,603,189,3511,842,794,237305,616,7272,882,044,9861,031,392,101214,205,1020-317,521,754
Dividend
Aug 28, 20190.024 CNY/sh

Profile

Kangmei Pharmaceutical Co., Ltd. produces and sells Chinese medicines in China. It also offers chemical drug products; and operates hospitals and Chinese medicine pharmacies. The company was founded in 1997 and is headquartered in Puning, China.
URL
http://www.kangmei.com.cn/
IPO date
Mar 19, 2001
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
4,874,016
16.60%
4,180,150
0.67%
4,152,521
-23.27%
Cost of revenue
5,056,352
4,223,335
4,151,231
Unusual Expense (Income)
NOPBT
(182,336)
(43,185)
1,290
NOPBT Margin
0.03%
Operating Taxes
6,800
30,270
235,389
Tax Rate
18,247.64%
NOPAT
(189,135)
(73,454)
(234,099)
Net income
102,521
 
7,917,901
 
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
26,137
64,736
52,065
Long-term debt
376,326
398,261
306,441
Deferred revenue
618,683
653,982
692,972
Other long-term liabilities
1,661,378
1,834,587
293,021
Net debt
(655,379)
(1,045,792)
(2,061,100)
Cash flow
Cash from operating activities
(317,522)
214,205
CAPEX
(99,745)
Cash from investing activities
(37,642)
Cash from financing activities
1,768,375
FCF
(1,054,686)
859,680
10,127,553
Balance
Cash
1,056,689
1,507,515
2,419,130
Long term investments
1,152
1,274
476
Excess cash
814,141
1,299,781
2,211,980
Stockholders' equity
(10,477,421)
14,239,068
14,536,319
Invested Capital
20,052,233
7,436,657
7,931,124
ROIC
ROCE
0.01%
EV
Common stock shares outstanding
10,252,123
13,863,867
13,863,867
Price
1.86
-15.45%
2.20
-28.80%
3.09
15.30%
Market cap
19,068,949
-37.48%
30,500,507
-28.80%
42,839,348
223.65%
EV
18,446,462
29,490,133
40,820,167
EBITDA
163,840
322,505
604,512
EV/EBITDA
112.59
91.44
67.53
Interest
56,154
78,897
1,022,031
Interest/NOPBT
79,229.02%